156 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific
8-K
EX-99.1
esi4 bdhpl2
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
424B4
iq1 rcfrds
29 Jan 24
Prospectus supplement with pricing info
4:15pm
8-K
EX-3.1
h3122me 0w4
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm